E. Fesce
Impact in
- Gastroenterology top 1%
- Gastrointestinal motility and disorders
- Hepatology top 5%
- Liver Disease and Transplantation
Papers in
- Surgery 8
- Organ Transplantation Techniques and Outcomes 3
-
- Gastrointestinal motility and disorders 7
- Co-authors
- Andrea Balsari (3 shared papers)Francesco Marotta (13 shared papers)F Dubini (1 shared paper)G. Poli (1 shared paper)G. Idéo (4 shared papers)G. Bellati (6 shared papers)Hisao Tajiri (5 shared papers)Patrick Safran (3 shared papers)
In The Last Decade
E. Fesce
33 papers receiving 681 citations
Peers
Comparison fields: 5 of 81
- Gastroenterology 275
- Hepatology 155
- Pharmacy 53
- Transplantation 14
- Complementary and Manual Therapy 10
Countries citing papers authored by E. Fesce
This map shows the geographic impact of E. Fesce's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Fesce with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Fesce more than expected).
Fields of papers citing papers by E. Fesce
This network shows the impact of papers produced by E. Fesce. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Fesce. The network helps show where E. Fesce may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Fesce, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The fecal microbial population in the irritable bowel syndrome. | 1982 | 197 |
| 2 | 1988 | 130 | |
| 3 | 2004 | 84 | |
| 4 | 1999 | 51 | |
| 5 | 2005 | 38 | |
| 6 | Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study. | 2004 | 29 |
| 7 | The prevalence of bile acid malabsorption in irritable bowel syndrome and the effect of cholestyramine : an uncontrolled open multicentre study | 1992 | 23 |
| 8 | 2004 | 13 | |
| 9 | Cyclosporin monotherapy (after 3 months) in liver transplant patients: a prospective randomized trial. | 1994 | 13 |
| 10 | 2007 | 12 | |
| 11 | 1985 | 12 | |
| 12 | 2010 | 12 | |
| 13 | Behaviour of gastric mucin during pirenzepine treatment: A double-blind controlled study versus cimetidine | 1980 | 10 |
| 14 | 2003 | 10 | |
| 15 | Ecophylaxis: preventive treatment with gentamicin of rabbit lincomycin-associated diarrhea. | 1978 | 9 |
| 16 | 1994 | 8 | |
| 17 | 2005 | 7 | |
| 18 | Intramuscular beta interferon for chronic hepatitis C: is it worth trying? | 1998 | 7 |
| 19 | 2006 | 6 | |
| 20 | 2006 | 6 |
About E. Fesce
E. Fesce is a scholar working on Surgery, Gastroenterology, Epidemiology, Nutrition and Dietetics and Hepatology, having authored 34 papers that have together received 722 indexed citations. Recurring topics across this work include Gastrointestinal motility and disorders (7 papers), Gut microbiota and health (4 papers), Liver Disease Diagnosis and Treatment (4 papers), Diet and metabolism studies (4 papers), Organ Transplantation Techniques and Outcomes (3 papers), Clostridium difficile and Clostridium perfringens research (3 papers), Liver Disease and Transplantation (3 papers) and Probiotics and Fermented Foods (3 papers). The work is most often cited by research in Gastroenterology (275 citations), Hepatology (155 citations), Pharmacy (53 citations), Transplantation (14 citations) and Complementary and Manual Therapy (10 citations). E. Fesce has collaborated with scholars based in Italy, Japan and Thailand. Frequent co-authors include Andrea Balsari, Francesco Marotta, F Dubini, G. Poli, G. Idéo, G. Bellati, Hisao Tajiri, Patrick Safran, G. Idéo and Yoshiro Naito. Their work appears in journals such as Digestion, Current Microbiology, Hepatology, Journal of Gastroenterology and Hepatology and Endoscopy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.